COMPOSITIONS CONTAINING AND METHODS OF USING 1-AMINOINDAN AND DERIVATIVES THEREOF AND PROCESS FOR PREPARING OPTICALLY ACTIVE 1-AMINOINDAN DERIVATIVES
申请人:——
公开号:US20020068839A1
公开(公告)日:2002-06-06
Novel derivatives of 1-aminoindan and their salts are described. Optically active 1-aminoindan derivatives are prepared by reacting a N-benzyl analog of the desired compound with an enantiomer of mandelic acid. Parkinson's disease, dementia, epilepsy, convulsions, or seizures are treated by administering a compound of the formula:
1
A process for producing an aryl carbamate of a high purity at a high yield by reacting a diaryl carbonate with an amine compound having one or more hydrogen atoms bonded to the N position in the presence of carboxylic acid(s) of the following general formulae (I): R1-COOH and/or (II): R2-COOH (wherein R1 represents an alkyl or cycloalkyl group having a carbon atom at the α-position, which is bonded to only one hydrogen atom, and R2 represents an alkyl group having a carbon atom at the α-position, which is not bonded to a hydrogen atom).
This invention provides a reagent for protein electrophoresis, an electrophoresis gel or buffer composition containing the reagent, and a protein separation method and an electrophoresis kit using the reagent and the composition.
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
申请人:Protagonist Therapeutics, Inc.
公开号:US10035824B2
公开(公告)日:2018-07-31
Peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel disease, are disclosed.